[go: up one dir, main page]

WO2012115675A1 - Procédé et appareil de suivi des patients - Google Patents

Procédé et appareil de suivi des patients Download PDF

Info

Publication number
WO2012115675A1
WO2012115675A1 PCT/US2011/041615 US2011041615W WO2012115675A1 WO 2012115675 A1 WO2012115675 A1 WO 2012115675A1 US 2011041615 W US2011041615 W US 2011041615W WO 2012115675 A1 WO2012115675 A1 WO 2012115675A1
Authority
WO
WIPO (PCT)
Prior art keywords
patient
data
patients
reminder
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2011/041615
Other languages
English (en)
Inventor
David Hold
Christina Mendez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TELE HOME CARE SOLUTION CO
Original Assignee
TELE HOME CARE SOLUTION CO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/033,116 external-priority patent/US20120035446A1/en
Priority claimed from US13/075,712 external-priority patent/US20120078964A1/en
Application filed by TELE HOME CARE SOLUTION CO filed Critical TELE HOME CARE SOLUTION CO
Priority to EP11859556.0A priority Critical patent/EP2702548A1/fr
Publication of WO2012115675A1 publication Critical patent/WO2012115675A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q10/00—Administration; Management
    • G06Q10/10—Office automation; Time management
    • G06Q10/109—Time management, e.g. calendars, reminders, meetings or time accounting
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00—ICT specially adapted for the handling or processing of medical references
    • G16H70/40—ICT specially adapted for the handling or processing of medical references relating to drugs, e.g. their side effects or intended usage

Definitions

  • This invention pertains to a method and apparatus for monitoring whether patients are taking their prescribed medicines from a remote location. Apparatus is further described for allowing a patient to determine his blood sugar level and to send this information to a remote location. This invention further pertains to a method and apparatus for monitoring diabetic patients who are treated with insulin and/or other drugs. In the present invention, the results of the tests are automatically recorded, uploaded to a data base and shared with health care providers b. Background of the Invention
  • Patients suffering various kinds of illnesses and other health-related issues are frequently prescribed medication that should be taken at regular intervals. These intervals may range from several hours to several days, Very often, patients have to take different medications at different times, with some of the medications being taken orally, while other may have to be injected or otherwise introduced or applied. Failure to take some or all of this medication can have serious consequences to the patient's health. However, it is believed that in fact many patients do not take their medication as required. This is especially frequent with elder patients who may forget or may get confused as to what medication they are required to take and/or when. At other times, elderly patients may take a medication inadvertently more often than required.
  • diabetes is a major disease that affects many patients throughout the world.
  • the disease pertains to the lack of a patient's body to either manufacture adequate supply and/or fails to utilize insulin in it metabolism. At present there is no cure for the disease but it can be manage thus allowing a patient a better quality of life.
  • This management includes testing the blood sugar of the patient one or more times a day and taking insulin and/or other drugs.
  • taking is used herein generically to any act of administering a drug to a patient, including administration of the drug by taking the drug orally, by injection, etc., and administering the drug by the patient or another person). Often both the testing and the administering are done by the patient himself.
  • the patient then visits his physician at somewhat regular intervals and gives the physician a list of the days on which his blood sugar was measured, the data obtained and the amount of medicine that the patient took.
  • the physician then analyzes this data and modifies the amount of insulin/drugs that the patient has to take in the future based on this analysis.
  • a microprocessor-based device to perform, a method of monitoring drug intake by a patient.
  • the method includes the steps of: receiving a prescription for a drug for a particular patient indicating a time for the taking of the drug by the patient;generating by said device a time schedule of the dates and times when the patient is to take the medicine; generating at the appropriate time a message to the patient indicating that the drug should be taken by the patient; and sending said message to the patient
  • a system wherein data is collected from a patient, such as a glucose meter at the patient site is obtained and automatically uploaded to a data base.
  • a master monitor reviews the data and collates it for the physician as needed.
  • the physician may obtain the data on a daily, weekly, monthly basis and/or during a visit by the patient.
  • the HbA1 c level in the blood is also measured at regular intervals (preferably monthly) at the patient site and data is also uploaded, stored in the data base, and reviewed by the physician to confirm the data from the glucose meter.
  • the central monitor can also be configured to monitor the data from each patient on a regular basis and to alert the physician and/or others if abnormal glucose levels are detected.
  • the communication channel used to collect the data is also used to (a) remind each patient to test his blood; and (b) take his medicine if no indicated. Each patient will be contacted as a reminder to complete this portion of the testing. The patient may also be asked to provide not only the test data but to confirm that he has taken his medicine (and/or has given himself on injection). This process has the added benefit of providing information to the master monitor and/or another service indicative of how much drugs the patient has, and, if necessary, to alert the physician, drug store, etc., that the patient is about to run out of a certain drug.
  • FIG. 1 shows a block diagram of a system incorporating the present invention
  • Fig. 2 shows a block diagram of a patient monitor apparatus used in the system of Fig. 1 ;
  • Fig. 3 shows a flow chart illustrating a patient registration stage
  • Fig. 4 shows a flow chart of the operation of the patient monitor
  • Fig. 5 shows a block diagram of a system configured in accordance with this invention for diabetes testing
  • Fig. 5A shows a diagrammatic view of a device used to test a blood sample for two different criteria
  • Fig. 6 shows a flow chart illustrating the operation of the system of
  • Fig. 7 shows a more proactive method for operating the system of Fig. 5.
  • the present invention provides a simple and yet effective means of overcoming the problems described above.
  • Several embodiments are described that not only remind the patient from a remote location at the right time to take a drug but, at least in some of the embodiments, provide a positive indication that the reminder has been received and acknowledged by the patient.
  • a patient has been dispensed one or more medications and that he has been issued proper instructions on when and how to take the medications.
  • the same information is simultaneously provided to a remote agent, e.g., an agent that is located outside the patient's home.
  • This agent is an automated apparatus that, in one embodiment, automatically contacts the patient at a designated date and time related to when the patient needs to take the medication.
  • a health care provider such as a hospital 12, a doctor 14, or other health care professional or entity 16 provides a prescription for a patient.
  • This prescription is either transmitted directly to a drug store A (or other similar dispensing entity) 18 or is given to a patient who then presents it to the drug store A 18.
  • This information is also sent to a patient monitor apparatus 20 by any one of the prescription suppliers, or by some other entity, such as a health insurance company.
  • the insurance company receives the information from the drug store 18 or by other means.
  • the patient monitor apparatus (or patient monitor, for short) 20 includes a microprocessor 30, a transceiver or other data communication device 32 and a data bank 34.
  • the data bank 34 is used to store all information relevant to various patients 22 in the system 10, including the information related to a particular prescription for one of the patients.
  • the patient registers and provides his critical information related to his health, as well as one more communications channels by which he can, or prefers to be reached. It should be noted that, except for the last part, all the other information is already required under various applicable laws by the drug store.
  • all the entities described, including the patient monitor 20 is arranged and configured to maintain this patient information secret and safe, again, in accordance with the applicable laws.
  • the patient 22 then receives the medication and relevant instructions from the respective health care provider 12, 14, 16 and/or the drug store 18, including when to take the medication, how often, and any other special instructions, such as whether to take the medication before or after a meal, and/or whether the medication should be taken certain foods or liquids, etc.
  • the instructions to the patient are also transmitted to the patient monitor 20 by the health care provider and/or the drug store 18.
  • the patient monitor 20 stores all this information and also establishes a schedule for prescription, including the medication and the special instructions specific to each patient 20.
  • the patient monitor 20 operates as shown in the flow chart of Fig. 4. That is, at a prescribed date and time, for example, the patient monitor 20 sends an automated alert message to the patient 22.
  • the mode of transmission and the form of the alert message is dependent on the patient's preferences, his location, his devices, etc. Possible modes of transmission could over a standard land-line telephone line, in which case the alert message typically consists of a voice mail indicating what medicine should be taken, when and any special instructions. Of course, preferably the message is sent to patient 20 at least a couple of minutes before the medicine is to be taken. Alternatively, the voice alert message could be sent to a cellular telephone, a pager, a VOIP device or other audible devices.
  • the alert message is sent by the patient monitor 20 as a text message to a cell phone, an e-mail address, a beeper, a pager, etc.
  • the alert message goes out to the patient, and a record is made by the microprocessor 30 that the message was sent.
  • the record of all messages are kept and presented to any authorized entity when requested.
  • the patient monitor 20 is configured to determine whether the alert message was actually received by determining either that the alert message was delivered to a live person or that it was recorded by an answering machine. For example, when a verbal message is sent to the patient 20, the patient may be requested to confirm that he has received the instructions by saying "YES", by pressing the number "1 " on his telephone, etc. If no confirmation is received within a predetermined time, then alert message is resent. The alert message can be resent in this manner several times. After N such tries, if confirmation is still not received then an appropriate record is stored for the patient 22. In addition, or alternatively, a separate message is sent to an appropriate entity (a health care provider (e.g., 12, 14) or a health care provider (e.g., 12, 14) or a health care provider (e.g., 12, 14) or a health care provider (e.g., 12, 14) or a health care provider (e.g., 12, 14) or a health care provider (e.g., 12, 14) or
  • the patient monitor 20 is also configured to receive an actual acknowledgement from the patient either that he has received the alert message, or that he has actually taken the medication. For example, either in the original message, or in a follow up message, the patient is asked to say “YES” or push the number “1 " if he has taken the medicine, and say “NO' or push the number "2" if he has not taken the medicine. The same process can be used to obtain an
  • acknowledgement to a text message. Again, if such a positive acknowledgement is expected, the patient monitor waits for a predetermined time for it, and if it is not received, the alert message is resent. If no acknowledgement is received, a record of this event is made and an appropriate alert message is sent to the appropriate entities, e.g . the health care provider and/or a relative. As previously indicated, the acknowledgment can be initiated by the patient by merely pushing a button on his land line or cell phone when he receives the alert message, or by sending a separate message to the patient monitor using any convenient channel.
  • the appropriate entities e.g . the health care provider and/or a relative.
  • the acknowledgment can be initiated by the patient by merely pushing a button on his land line or cell phone when he receives the alert message, or by sending a separate message to the patient monitor using any convenient channel.
  • the patient monitor can be made an integral part of any of the entities generating the prescription, the drug store, or some other entity providing other services for any of the parties discussed.
  • the system can be easily implemented even if the patient goes to several different drug stores, such as drug store B. If a given patient is prescribed several medications, the alert message can cover all them, or alternatively, several alert messages can be sent to the same patient as required..
  • the information recorded from the patient can be made available to the doctor, the hospital, the drug store, the insurance company, to insure that the patient is taking his medicine or for various medical studies.
  • the patient monitor is further adapted to aggregate the data in the data bank 34 and generate various reports that do not include the actual patient identification, such as how many patients were prescribed drug X in a given month, how many patients actually took drug X in that month, how many patients obtained their drugs from drug store A, how many patients obtained their drugs from drug store B and so forth.
  • Another type of report may indicate information about which health care provider or how many health care providers prescribed a drug Y as opposed to a similar drug Z, how often was a patient instructed to take a drug, etc.
  • Another type of report may be include a cost analysis based on what various drug stores charged for either a specific drug, or a specific type of drug.
  • a system 510 constructed in accordance with this invention includes several elements. Some of the elements are at a patient site while others are at one or more remote locations that are interconnected by the Internet, a private communication, network and could be cloud-based.
  • a glucose tester that is similar to testers available from various sources in that it is able to accept s a blood sample from the patient, either directly, or via a strip provided for this purpose.
  • the glucose tester determines the current sugar concentration in the blood of the patient. Once this determination is made, the resulting number as well as the current date and time are stored in a data memory 514.
  • a modem 516 that is connected to the data memory to transmit the data recorded therein to a remote location.
  • the modem 516 includes a USB port, a jack for a land-line telephone, a port for a cell phone connection and/or any other similar port that can be used to establish data communication with the remote location.
  • A1 C tester 518 receives a blood sample and determines the HbA1 c level therein. Testers of this sort are presently available, for example, from Bayer, however, they merely provide a reading and do not transmit it anywhere. Instead the results are recorded manually. In the present invention, the recording from the A1 c tester are also recorded in the same data memory 514 or a separate data memory and are then transmitted by modem 516 as well.
  • Fig. 5 can be implemented in a number of different configuration.
  • two separate independent testers are provided, each performing its own test, data storage and modem.
  • two physically separate testers are provided that share a data memory and/or modem.
  • the testers 512, 518, the data memory 514 or memories and the modem 516 or modems are disposed in a single hand held unit.
  • the system further includes a master monitor 520 that is connected to a central data bank 522.
  • the central data bank receives information and stores from the modem 516 via a communication channel 524, as well as similar information from other patients.
  • the master monitor 520 sets up what information is to receive in order to establish an effective diabetes management process for each patient.
  • the master monitor exchange information with several physicians, or other health care providers and/or pharmacies and hospitals, all commonly indicated in Fig. 5 by numeral 526.
  • the master controller 520 can also provide a reminder service 528 to its patients, and if necessary, activate an emergency service 530.
  • Fig. 5A shows a somewhat diagrammatic representation of a device 40 used to collect data.
  • the device includes two ports or other means 42, 44 for receiving respectively a sample of blood for testing sugar level and A1 c,
  • the device 40 further includes several communication ports 50, 52, 54 that may be, respectively, a USB port, an Ethernet port, a phone jack/wireless access port, etc.
  • the result together with other information, such as the type of test, the date and the time, are shown on a screen 56, typically an LCD screen.
  • the result is also stored in the data memory 14.
  • the patient then activates a button 58 requesting that the information be sent to a remote location. Alternatively, the data can be sent automatically.
  • Device 40 is also provided with several indication lights 60, 62, 64.
  • Light 60 may be used to alert the patient that it is time for a test an/or the administration of a drug.
  • Light 62 may be used to indicate to the patient that the data has been correctly received and stored, or that the data seems to be wrong and the test should be repeated.
  • Light 64 may be used for other indication, such as a reminder or a request that he should visit his physician or other health care provider, or that his medicine is about to run out and should obtain a new supply.
  • the patient is provided with two devices.
  • One deice is similar to the device of Fig. 5A but only takes daily measurements, stores them and transmits them as described above.
  • a second device is used to make the A1 c test, for example, monthly.
  • the patient enters the results manually into the first device which then transmits it together with any other data it may have collected.
  • step 100 a patient registers with the system and at least some of the following information is collected. This can be done in various forms, such as having the patient fill in a form manually or electronically:
  • n Any kind of authorization for billing insurance or Medicare/Medicaid Patients and any consent form to collect demographic information.
  • o Any information for supplies and prescription from the physician in order to bill for these supplies,
  • step 1 10 information not received from the patient is obtained from another source, such as the physician.
  • This information may include the amount of drugs required for the the patient, etc.
  • step 120 the physician or other competent authority sets up a monitoring schedule and several levels of alarm levels for various events as defined above for j, k and I.
  • the central monitor 520 has only the
  • the management process also defines (as set by or suggested by the physician) what are the normal sugar levels, under what conditions should physicians and/or others, such as an alternate care giver, a relative or other responsible person, or, in extreme cases, an emergency service should be notified. All this information is stored in the data bank 22 and the system is now ready for operation.
  • step 130 data is collected from each patient device, stored in the data bank 522 and analyzed.
  • step 140 a determination is made if the data is within certain ranges as previously defined for each patient. If the data is within range, data collection continues in step 130. If the data exceeds a certain range or meets some other criteria, as initially defined, an alarm condition is established and data collection is continued for the other patients. Depending on preset thresholds, when an abnormal sugar level is indicated, notifications are sent automatically to the patient's physician an alternate giver, family member, emergency services, etc.
  • authorized personnel including a patient's primary physician, is issued a password to allow the physician to access the patient's records at any time.
  • the physician can access the records just before, or during a standard (e.g., monthly visit), or when receiving an emergency message.
  • the data collection of step 130 can be implemented in various ways. For example, data can be collected asynchronously, whenever the analysis of a blood sample has been completed. Preferably, after the data is transmitted, the data bank and/or monitor analyzes the data to check if it is correct and then sends an acknowledgement that either turns on one of the indicator lights or activates a message on the screen 56 indicating that the test has been successful.
  • test data is stored in the memory, and the data bank poles all the data memory of the serviced patients and collects the data sequentially.
  • the process may start in step 200 by sending a reminder to the patient to take his medicine.
  • This step may be implemented by either activating a light on the device ( as discussed above in relation to Fig. 1 C) or by other means.
  • the patient may receive an oral or text message on a land-line telephone, cell phone, e-mail, text message, etc.
  • step 210 the monitor looks for an acknowledgement from the patient that he has taken the medicine or at least has received the reminder. If no acknowledgement is received, an appropriate alert is sent to the physicians, relatives or others in step 220.
  • step 230 the monitor checks when was the last time the patient received a supply of drugs and whether that supply is getting low, the patient, or the drug store are alerted (steps 240, 250).
  • step 260 the patient is sent a reminder that he needs to test his blood sugar level. If this reminder is acknowledged (step 270, for example by pressing an appropriate button on device 40), then in step 290 the results are stored and then analyzed as previously discussed. If the reminder for a blood test is not acknowledged, an alert is sent to the physicians and/or others (step 280).
  • determining how much drugs the patient should have can be made independently of the reminders.
  • the reminder to check for blood sugar may be before sending the reminder to administer drugs.

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Business, Economics & Management (AREA)
  • Medical Informatics (AREA)
  • Human Resources & Organizations (AREA)
  • Public Health (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Business, Economics & Management (AREA)
  • Strategic Management (AREA)
  • Entrepreneurship & Innovation (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Data Mining & Analysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Economics (AREA)
  • Marketing (AREA)
  • Operations Research (AREA)
  • Quality & Reliability (AREA)
  • Tourism & Hospitality (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Theoretical Computer Science (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)

Abstract

L'invention concerne un système et un procédé comprenant une entité à base de micro-processeur recevant des prescriptions d'un grand nombre de patients différents. Un protocole est généré pour chaque prescription et, à un instant approprié, un rappel est envoyé à chaque patient pour lui indiquer de prendre son médicament. Le système peut également être utilisé pour suivre les patients diabétiques. Les patients diabétiques reçoivent des testeurs de glycémie qui sont utilisés pour vérifier le niveau de glycémie des patients chez eux. Les données de glycémie provenant des testeurs sont automatiquement transmises à une banque de données qui recueille les données quotidiennes en provenance d'une pluralité de patients et présente les données au médecin lorsque cela est nécessaire. Les patients peuvent également recevoir des testeurs A1 c qui mesurent et transmettent à la banque de données les données A1 c recueillies mensuellement.
PCT/US2011/041615 2011-02-23 2011-06-23 Procédé et appareil de suivi des patients Ceased WO2012115675A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP11859556.0A EP2702548A1 (fr) 2011-02-23 2011-06-23 Procédé et appareil de suivi des patients

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US13/033,116 2011-02-23
US13/033,116 US20120035446A1 (en) 2010-08-05 2011-02-23 Method and apparatus for monitoring diabetic patients
US13/075,712 2011-03-30
US13/075,712 US20120078964A1 (en) 2010-03-30 2011-03-30 System for storing and diseminating patient data and related information

Publications (1)

Publication Number Publication Date
WO2012115675A1 true WO2012115675A1 (fr) 2012-08-30

Family

ID=46721528

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2011/041615 Ceased WO2012115675A1 (fr) 2011-02-23 2011-06-23 Procédé et appareil de suivi des patients

Country Status (2)

Country Link
EP (1) EP2702548A1 (fr)
WO (1) WO2012115675A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016185369A1 (fr) * 2015-05-15 2016-11-24 J. Brasch Co., Llc Système et procédé de surveillance active d'une personne

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040249250A1 (en) * 2003-06-04 2004-12-09 Mcgee Michael D. System and apparatus for monitoring and prompting medical self-care events and communicating medical self-care status
US20080114689A1 (en) * 2006-11-03 2008-05-15 Kevin Psynik Patient information management method
US20090063193A1 (en) * 2007-08-31 2009-03-05 Mike Barton Dashboard diagnostics for wireless patient communicator
US20090118596A1 (en) * 2002-04-16 2009-05-07 Carematix, Inc. Method and Apparatus for Remotely Monitoring the Condition of a Patient

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090118596A1 (en) * 2002-04-16 2009-05-07 Carematix, Inc. Method and Apparatus for Remotely Monitoring the Condition of a Patient
US20040249250A1 (en) * 2003-06-04 2004-12-09 Mcgee Michael D. System and apparatus for monitoring and prompting medical self-care events and communicating medical self-care status
US20080114689A1 (en) * 2006-11-03 2008-05-15 Kevin Psynik Patient information management method
US20090063193A1 (en) * 2007-08-31 2009-03-05 Mike Barton Dashboard diagnostics for wireless patient communicator
US20090062887A1 (en) * 2007-08-31 2009-03-05 William Mass Wireless patient communicator for use in a life critical network

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016185369A1 (fr) * 2015-05-15 2016-11-24 J. Brasch Co., Llc Système et procédé de surveillance active d'une personne
GB2555746A (en) * 2015-05-15 2018-05-09 J Brasch Co Llc System and method for active monitoring of a person
GB2555746B (en) * 2015-05-15 2020-02-12 J Brasch Co Llc System and method for active monitoring of a person
US10593185B2 (en) 2015-05-15 2020-03-17 J. Brasch Co., Llc System and method for active monitoring of a person

Also Published As

Publication number Publication date
EP2702548A1 (fr) 2014-03-05

Similar Documents

Publication Publication Date Title
US11923083B2 (en) Method and apparatus for verification of medication administration adherence
Saunders et al. Group health cooperative of puget sound
US20190378601A1 (en) Apparatus and method for collection of protocol adherence data
Szczepura et al. Medication administration errors for older people in long-term residential care
US20060184393A1 (en) Online medical data collection
US20070167688A1 (en) Healthcare management systems and associated methods
US20080215374A1 (en) Clinical management system and methods
JP7742434B2 (ja) 受診管理システム、リマインド方法、病院端末、および、プログラム
EP2502199A1 (fr) Procédé et appareil permettant de vérifier l'adhésion à l'administration de médicaments
US20050114182A1 (en) Method and apparatus for generating patient reminders
US20120035446A1 (en) Method and apparatus for monitoring diabetic patients
WO2012115675A1 (fr) Procédé et appareil de suivi des patients
US20110170378A1 (en) Method and apparatus for monitoring medication intake by patients
Biermann et al. Future of telemedicine in heart disease
WO2020121238A1 (fr) Système d'aide au soin centrée sur le patient et son procédé
JP2002297780A (ja) 医療施設提携支援システム
US20160048656A1 (en) System for using medication samples to measure medication acquisition and improve patient outcomes

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11859556

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

REEP Request for entry into the european phase

Ref document number: 2011859556

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2011859556

Country of ref document: EP